CompletedNot Applicable

Femoral Lengthening Might Impair Physical Function and Lead to Structural Changes in Adjacent Joints

Norway10 participantsStarted 2019-03-06

Plain-language summary

This study evaluates function, quality of life and development of hip- and knee osteoarthritis minimum 15 years after unilateral femoral lengthening on people with idiopathic or post-traumatic anisomelia.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with idiopathic or post traumatic leg length discrepancy who are lengthened with the callutasis method minimum 15 years ago Exclusion Criteria: * Patients that are lenghtened with innate pathology resulting in shortening of the limb, angle deviation and less musculature, for example congenital femoral deficiency or fibula hemimelia. * Patients with acquired leg length discrepancy who have had infection in knee or hip joint

What they're measuring

hip or knee osteoarthritis

Timeframe: One day

Lower extremity strength

Timeframe: one day

Lower extremity function

Timeframe: one day

Aerob capasity

Timeframe: one day

measure of health related quality of life with EQ-5D-5L

Timeframe: one day

measure of function and pain with Knee Osteoarthritis Outcome Score (KOOS)

Timeframe: one day

measuring physical activity level with International Physical Activity Questionnaire (IPAQ)

Timeframe: one day

Active range of motion

Timeframe: one day

Trial details

NCT IDNCT03966573

SponsorOslo University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-10-11

View on ClinicalTrials.gov More Leg Length Inequality trials